Plenary Speakers

Ali Khademhosseini, Ph.D.

Engineering in Precision Medicine

CEO and Founding Director, Terasaki Institute for Biomedical Innovation


Theodore Miclau, M.D.

Collaborative Musculoskeletal Research Networks: Creating an Impact Worldwide

Department of Orthopaedic Surgery University of California, San Francisco


Peter Visscher, PhD, FRS, FAA

The polygenic revolution in human complex trait genetics:from gene discovery to phenotype prediction

Co presenting with Naomi Wray
Institute for Molecular Bioscience, The University of Queenland


Naomi Wray, PhD, FAA, FAHMS

The polygenic revolution in human complex trait genetics:from gene discovery to phenotype prediction

Co Presenting with Peter Visscher
Institute for Molecular Bioscience, The University of Queenland


Keynote Speakers

Frank Beier, Ph.D.

Animal models of osteoarthritis

Department of Physiology and Pharmacology, University of Western Ontario


Anthony Bull, Ph.D. FREng

Engineering solutions for severe musculoskeletal trauma

Imperial College London, UK


Matt Dalby, Ph.D.

Nanoscale materials to direct mesenchymal stem cell growth and differentiation

Centre for the Cellular Microenvironment, University of Glasgow


Mackenzie Hagan, Ph.D.

Validation of an in vivo mechanical loading model using DXA-derived BMD analysis

Applications Scientist, KUBTEC Scientific, USA


Andrew C. Hall, Ph.D.

Cartilage loss in osteoarthritis - a problem with the chondrocyte phenotype?

Edinburgh Medical School, University of Edinburgh


Francis Lee, M.D., Ph.D.

Experimental animal models and mechanisms portraying clinical dilemmas of Impaired fracture healing

Wayne O. Southwick Professor, Yale University U.S.A.


Christine Le Maitre, Ph.D.

Developing therapeutic strategies to promote intervertebral disc regeneration

Biomolecular Sciences Research Centre Sheffield Hallam University


Ali Mobasheri, DPhil (Oxon).

Osteoarthritis phenotypes and endotypes: what do we know and what can we learn from other disease areas to develop targeted treatments?

Faculty of Medicine,  University of Oulu,  Finland


Pankaj Pankaj, PhD.

Novel in silico approaches to optimise fracture treatment

Institute for Bioengineering, School of Engineering, The University of Edinburgh


Bruno Peault, PhD.

A view to mesenchymal stem cells, in and out of the niche

University of Edinburgh and University of California, Los Angeles


Katharina Schmidt-Bleek, PD Dr. rer. nat.

The importance of the immune reaction during bone regeneration

Biology of Bone Healing, Julius Wolff Institut, Charité - Universitätsmedizin Berlin


Fiona Watt, PhD

Prevention of Post-traumatic osteoarthritis: Pipedream or reality?

Imperial College London


Eleftheria Zeggini, PhD

The genomic aetiology of osteoarthritis

Institute of Translational Genomics, Helmholtz Munich


  • Deadlines
    All the key dates, listed in one place
  • Social Events
    Social Events
    Take time to relax, meet old friends, and make new ones!


The International Combined Orthopaedic Research Societies (ICORS) serves as an alliance of societies to promote basic, translational, and clinical musculoskeletal research worldwide. The Combined Meeting was launched in 1992 and has convened every three years since On October 15, 2013, at the 8th Combined Meeting of the Orthopaedic Research Societies hosted by the European Orthopaedic Research in Venice, Italy, a new alliance was formed; the International Combined Orthopaedic Research Societies. Nine organizations were selected and approved as the founding members; Australia/New Zealand ORS, British ORS, Canadian ORS, Chinese ORS, European ORS, Japanese Orthopaedic Association, Korean ORS, the Orthopaedic Research Society, and the Taiwanese ORS.


ICORS 2022 Disclaimer 

Get in touch

ICORS 2022

If you have any questions or suggestions, please contact us: ICORS2022CHARACTER or click to email.